Arkema Share: a 2.5% rebound among the strongest gains in the SBF 120
The specialty chemicals company rebounds sharply in mid-morning and makes it into the top of the index table, in a Paris market that is also well-oriented. This rebound comes after a price target adjustment by a major American broker, and while the chemical sector is suffering from a sluggish industrial cycle over recent months.
A rebound that brings the price back to its 20-day moving average
The Arkema share gains 2.29% to €55.75, placing it among the strongest gainers in the SBF 120, which advances 0.58% at the same time. The security thus touches its MA20 (€55.64), after moving away from its MA50 (€58.16), still 4.14% above the current price, as is the MA200 (€57.75). The support at €54 remains close, resistance at €59.95 more distant, and the RSI at 36 indicates a still fragile configuration despite today's rally. Over one month, the share declines 2.19%, a decline that the session reduces without fully offsetting.
Morgan Stanley lowers its price target from €62 to €60
On October 12, Morgan Stanley lowered its price target from €62 to €60, while maintaining its market-weight rating. This target leaves an upside potential of approximately 7.6% compared to the current price. Among the recent developments for the group, Arkema inaugurated on October 8 in Carling an acrylic acid purification unit that reduces the site's carbon intensity by 20%. For tracking the security, the complete analyst consensus can be viewed on the Arkema analyst opinions page.
